Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 319

1.

A cost-effectiveness analysis of trastuzumab-containing treatment sequences for HER-2 positive metastatic breast cancer patients in Taiwan.

Diaby V, Alqhtani H, van Boemmel-Wegmann S, Wang CY, Ali AA, Balkrishnan R, Ko Y, Palacio S, de Lima Lopes G.

Breast. 2019 Nov 26;49:141-148. doi: 10.1016/j.breast.2019.11.012. [Epub ahead of print]

2.

Opioid Epidemic or Pain Crisis? Using the Virginia All Payer Claims Database to Describe Opioid Medication Prescribing Patterns and Potential Harms for Patients With Cancer.

LeBaron VT, Camacho F, Balkrishnan R, Yao NA, Gilson AM.

J Oncol Pract. 2019 Dec;15(12):e997-e1009. doi: 10.1200/JOP.19.00149. Epub 2019 Nov 4.

PMID:
31682546
3.

Examining factors associated with adherence to hormonal therapy in breast cancer patients.

Shah CH, Balkrishnan R, Diaby V, Xiao H.

Res Social Adm Pharm. 2019 Aug 1. pii: S1551-7411(19)30174-3. doi: 10.1016/j.sapharm.2019.08.005. [Epub ahead of print]

PMID:
31473108
4.

Mental Health Comorbidities and Elevated Risk of Opioid Use in Elderly Breast Cancer Survivors Using Adjuvant Endocrine Treatments.

Desai R, Camacho F, Tan X, LeBaron V, Blackhall L, Balkrishnan R.

J Oncol Pract. 2019 Sep;15(9):e777-e786. doi: 10.1200/JOP.18.00781. Epub 2019 Jul 19.

PMID:
31322988
5.

Environmental and individual predictors of medication adherence among elderly patients with hypertension and chronic kidney disease: A geospatial approach.

Han Y, Saran R, Erickson SR, Hirth RA, He K, Balkrishnan R.

Res Social Adm Pharm. 2019 Jun 22. pii: S1551-7411(19)30019-1. doi: 10.1016/j.sapharm.2019.06.011. [Epub ahead of print]

PMID:
31253498
6.

Antihypertensive drug use and blood pressure control among stroke survivors in the United States: NHANES 2003-2014.

Sonawane K, Zhu Y, Balkrishnan R, Suk R, Sharrief A, Deshmukh AA, Aguilar D.

J Clin Hypertens (Greenwich). 2019 Jun;21(6):766-773. doi: 10.1111/jch.13553. Epub 2019 May 17.

7.

Fondaparinux Sodium Compared With Low-Molecular-Weight Heparins for Perioperative Surgical Thromboprophylaxis: A Systematic Review and Meta-analysis.

Kumar A, Talwar A, Farley JF, Muzumdar J, Schommer JC, Balkrishnan R, Wu W.

J Am Heart Assoc. 2019 May 21;8(10):e012184. doi: 10.1161/JAHA.119.012184.

8.

The association between geographic access to providers and the treatment quality of pediatric depression.

Upadhyay N, Aparasu R, Rowan PJ, Fleming ML, Balkrishnan R, Chen H.

J Affect Disord. 2019 Jun 15;253:162-170. doi: 10.1016/j.jad.2019.04.091. Epub 2019 Apr 22.

PMID:
31035217
9.

Interrelationship Between Health Insurance Status and Prostate Cancer Grade Can Have Critical Impact on Prostate Cancer Disease Control: A Retrospective Cohort Study.

Awasthi S, Gerke T, Williams VL, Asamoah F, Fink AK, Balkrishnan R, Park JY, Yamoah K.

Cancer Control. 2019 Jan-Dec;26(1):1073274819837184. doi: 10.1177/1073274819837184.

10.

Mental Health Services in Childhood: The Role of Family Adversity.

Alcalá HE, Balkrishnan R.

Public Health Rep. 2019 Mar/Apr;134(2):180-188. doi: 10.1177/0033354919826555.

PMID:
30844343
11.

Secular Trends in the Cost of Immunosuppressants after Solid Organ Transplantation in the United States.

Helmuth ME, Liu Q, Turenne MN, Park JM, Oguntimein M, Dutcher SK, Balkrishnan R, Sharma P, Zee J, Leichtman AB, Smith AR.

Clin J Am Soc Nephrol. 2019 Mar 7;14(3):421-430. doi: 10.2215/CJN.10590918. Epub 2019 Feb 28.

PMID:
30819667
12.

US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Robinson B, Abbott KC, Agodoa LYC, Bragg-Gresham J, Balkrishnan R, Bhave N, Dietrich X, Ding Z, Eggers PW, Gaipov A, Gillen D, Gipson D, Gu H, Guro P, Haggerty D, Han Y, He K, Herman W, Heung M, Hirth RA, Hsiung JT, Hutton D, Inoue A, Jacobsen SJ, Jin Y, Kalantar-Zadeh K, Kapke A, Kleine CE, Kovesdy CP, Krueter W, Kurtz V, Li Y, Liu S, Marroquin MV, McCullough K, Molnar MZ, Modi Z, Montez-Rath M, Moradi H, Morgenstern H, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O'Hare AM, Obi Y, Park C, Pearson J, Pisoni R, Potukuchi PK, Repeck K, Rhee CM, Schaubel DE, Schrager J, Selewski DT, Shamraj R, Shaw SF, Shi JM, Shieu M, Sim JJ, Soohoo M, Steffick D, Streja E, Sumida K, Kurella Tamura M, Tilea A, Turf M, Wang D, Weng W, Woodside KJ, Wyncott A, Xiang J, Xin X, Yin M, You AS, Zhang X, Zhou H, Shahinian V.

Am J Kidney Dis. 2019 Mar;73(3S1):A7-A8. doi: 10.1053/j.ajkd.2019.01.001. Epub 2019 Feb 21. No abstract available.

13.

Examining HPV Vaccination Practices and Differences Among Providers in Virginia.

Alcalá HE, Maxwell GL, Lindsay B, Keim-Malpass J, Mitchell EM, Balkrishnan R.

J Cancer Educ. 2020 Feb;35(1):159-164. doi: 10.1007/s13187-018-1455-0.

PMID:
30520008
14.

Optimizing Time to Treatment to Achieve Durable Biochemical Disease Control after Surgery in Prostate Cancer: A Multi-Institutional Cohort Study.

Awasthi S, Gerke T, Park JY, Asamoah FA, Williams VL, Fink AK, Balkrishnan R, Lee DI, Malkowicz SB, Lal P, Dhillon J, Pow-Sang JM, Rebbeck TR, Yamoah K.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):570-577. doi: 10.1158/1055-9965.EPI-18-0812. Epub 2018 Nov 9.

PMID:
30413401
15.

Satisfied patients and pediatricians: a cross-sectional analysis.

Patel I, Chapman T, Camacho F, Shrestha S, Chang J, Balkrishnan R, Feldman SR.

Patient Relat Outcome Meas. 2018 Aug 28;9:299-307. doi: 10.2147/PROM.S161621. eCollection 2018.

16.

Does Risk Adjustment Reduce Vaccination in the Elderly? Evidence From Medicare Advantage.

Lissenden B, Balkrishnan R.

Med Care Res Rev. 2018 Jul 1:1077558718785559. doi: 10.1177/1077558718785559. [Epub ahead of print]

PMID:
29998793
17.

Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States.

Siontis KC, Zhang X, Eckard A, Bhave N, Schaubel DE, He K, Tilea A, Stack AG, Balkrishnan R, Yao X, Noseworthy PA, Shah ND, Saran R, Nallamothu BK.

Circulation. 2018 Oct 9;138(15):1519-1529. doi: 10.1161/CIRCULATIONAHA.118.035418. Erratum in: Circulation. 2018 Oct 9;138(15):e425.

18.

Temporal Trends and Factors Associated with Medication Prescription Patterns in Peritoneal Dialysis Patients.

Campos LG, Bragg-Gresham J, Han Y, Moraes TP, Figueiredo AE, Barretti P, Balkrishnan R, Saran R, Pecoits-Filho R; BRAZPD Investigators.

Perit Dial Int. 2018 Jul-Aug;38(4):293-301. doi: 10.3747/pdi.2017.00187. Epub 2018 Jun 6.

PMID:
29875177
19.

The adoption of generic immunosuppressant medications in kidney, liver, and heart transplantation among recipients in Colorado or nationally with Medicare part D.

Liu Q, Smith AR, Park JM, Oguntimein M, Dutcher S, Bello G, Helmuth M, Turenne M, Balkrishnan R, Fava M, Beil CA, Saulles A, Goel S, Sharma P, Leichtman A, Zee J.

Am J Transplant. 2018 Jul;18(7):1764-1773. doi: 10.1111/ajt.14722. Epub 2018 Mar 31.

20.

US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Robinson B, Abbott KC, Agodoa LYC, Bhave N, Bragg-Gresham J, Balkrishnan R, Dietrich X, Eckard A, Eggers PW, Gaipov A, Gillen D, Gipson D, Hailpern SM, Hall YN, Han Y, He K, Herman W, Heung M, Hirth RA, Hutton D, Jacobsen SJ, Jin Y, Kalantar-Zadeh K, Kapke A, Kovesdy CP, Lavallee D, Leslie J, McCullough K, Modi Z, Molnar MZ, Montez-Rath M, Moradi H, Morgenstern H, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O'Hare AM, Obi Y, Park C, Pearson J, Pisoni R, Potukuchi PK, Rao P, Repeck K, Rhee CM, Schrager J, Schaubel DE, Selewski DT, Shaw SF, Shi JM, Shieu M, Sim JJ, Soohoo M, Steffick D, Streja E, Sumida K, Tamura MK, Tilea A, Tong L, Wang D, Wang M, Woodside KJ, Xin X, Yin M, You AS, Zhou H, Shahinian V.

Am J Kidney Dis. 2018 Mar;71(3 Suppl 1):A7. doi: 10.1053/j.ajkd.2018.01.002. No abstract available. Erratum in: Am J Kidney Dis. 2018 Apr;71(4):501.

21.

The Effect of False-positive Mammograms on Antidepressant and Anxiolytic Initiation.

Segel JE, Balkrishnan R, Hirth RA.

Med Care. 2017 Aug;55(8):752-758. doi: 10.1097/MLR.0000000000000760.

PMID:
28650923
22.

Opioid use among female breast cancer patients using different adjuvant endocrine therapy regimens.

Tan X, Camacho TF, LeBaron VT, Blackhall LJ, Balkrishnan R.

Breast Cancer Res Treat. 2017 Sep;165(2):455-465. doi: 10.1007/s10549-017-4348-8. Epub 2017 Jun 21.

PMID:
28639031
23.

Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors.

Camacho FT, Tan X, Alcalá HE, Shah S, Anderson RT, Balkrishnan R.

Medicine (Baltimore). 2017 Jun;96(24):e7147. doi: 10.1097/MD.0000000000007147.

24.

A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer.

Garcia C, Yao A, Camacho F, Balkrishnan R, Cantrell LA.

Gynecol Oncol. 2017 Aug;146(2):346-350. doi: 10.1016/j.ygyno.2017.05.006. Epub 2017 May 10.

PMID:
28499649
25.

Reply.

Parikh ND, Singal AG, Lok AS, Balkrishnan R, Shahinian V, Marshall VD.

Hepatology. 2017 Aug;66(2):679-680. doi: 10.1002/hep.29248. Epub 2017 Jun 28. No abstract available.

26.

US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Robinson B, Abbott KC, Agodoa LY, Albertus P, Ayanian J, Balkrishnan R, Bragg-Gresham J, Cao J, Chen JL, Cope E, Dharmarajan S, Dietrich X, Eckard A, Eggers PW, Gaber C, Gillen D, Gipson D, Gu H, Hailpern SM, Hall YN, Han Y, He K, Hebert H, Helmuth M, Herman W, Heung M, Hutton D, Jacobsen SJ, Ji N, Jin Y, Kalantar-Zadeh K, Kapke A, Katz R, Kovesdy CP, Kurtz V, Lavalee D, Li Y, Lu Y, McCullough K, Molnar MZ, Montez-Rath M, Morgenstern H, Mu Q, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O'Hare AM, Obi Y, Pearson J, Pisoni R, Plattner B, Port FK, Potukuchi P, Rao P, Ratkowiak K, Ravel V, Ray D, Rhee CM, Schaubel DE, Selewski DT, Shaw S, Shi J, Shieu M, Sim JJ, Song P, Soohoo M, Steffick D, Streja E, Tamura MK, Tentori F, Tilea A, Tong L, Turf M, Wang D, Wang M, Woodside K, Wyncott A, Xin X, Zang W, Zepel L, Zhang S, Zho H, Hirth RA, Shahinian V.

Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2016.12.004. Review. No abstract available. Erratum in: Am J Kidney Dis. 2017 May;69(5):712.

27.

Polio and cross-border management.

Khan MU, Ahmad A, Balkrishnan R.

Lancet Infect Dis. 2017 Feb;17(2):136. doi: 10.1016/S1473-3099(17)30012-9. No abstract available.

PMID:
28134106
28.

Disparities in recommended preventive care usage among persons living with diabetes in the Appalachian region.

Sohn MW, Kang H, Park JS, Yates P, McCall A, Stukenborg G, Anderson R, Balkrishnan R, Lobo JM.

BMJ Open Diabetes Res Care. 2016 Dec 23;4(1):e000284. doi: 10.1136/bmjdrc-2016-000284. eCollection 2016.

29.

Could an automated machine replace the pharmacist?

Khan MU, Ahmad A, Malik S, Balkrishnan R.

Res Social Adm Pharm. 2017 Mar - Apr;13(2):399. doi: 10.1016/j.sapharm.2016.10.019. Epub 2016 Nov 18. No abstract available.

PMID:
27884658
30.

First-Line Fixed-Combination Psoriasis Treatment Is Associated With Lower Healthcare Costs.

Feldman SR, Levi E, Pathak P, Kakatkar S, Balkrishnan R.

Skinmed. 2016 Aug 1;14(4):266-272. eCollection 2016.

PMID:
27784515
31.

Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: An analysis of the SEER-Medicare database.

Parikh ND, Marshall VD, Singal AG, Nathan H, Lok AS, Balkrishnan R, Shahinian V.

Hepatology. 2017 Jan;65(1):122-133. doi: 10.1002/hep.28881. Epub 2016 Nov 25.

32.

Cardiovascular Disease Outcomes Associated with Three Major Inflammatory Dermatologic Diseases: A Propensity-Matched Case Control Study.

Marshall VD, Moustafa F, Hawkins SD, Balkrishnan R, Feldman SR.

Dermatol Ther (Heidelb). 2016 Dec;6(4):649-658. Epub 2016 Sep 22.

33.

Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer.

Tan X, Camacho F, Marshall VD, Donohoe J, Anderson RT, Balkrishnan R.

Res Social Adm Pharm. 2017 Jul - Aug;13(4):796-810. doi: 10.1016/j.sapharm.2016.08.004. Epub 2016 Aug 25.

34.

Cancer Disparities in Rural Appalachia: Incidence, Early Detection, and Survivorship.

Yao N, Alcalá HE, Anderson R, Balkrishnan R.

J Rural Health. 2017 Sep;33(4):375-381. doi: 10.1111/jrh.12213. Epub 2016 Sep 7.

PMID:
27602545
35.

Prescription to over-the-counter switches in the United States.

Chang J, Lizer A, Patel I, Bhatia D, Tan X, Balkrishnan R.

J Res Pharm Pract. 2016 Jul-Sep;5(3):149-54. doi: 10.4103/2279-042X.185706. Review.

36.

Evaluating and Comparing Methods for Measuring Spatial Access to Mammography Centers in Appalachia (Re-Revised).

Donohoe J, Marshall V, Tan X, Camacho FT, Anderson R, Balkrishnan R.

Health Serv Outcomes Res Methodol. 2016 Jun;16(1):22-40. Epub 2016 Jan 12.

37.

Fixed-dose combination antibiotics in India: global perspectives.

Ahmad A, Khan MU, Balkrishnan R.

Lancet Glob Health. 2016 Aug;4(8):e521. doi: 10.1016/S2214-109X(16)30093-6. No abstract available.

38.

Hidradenitis Suppurativa Management in the United States: An Analysis of the National Ambulatory Medical Care Survey and MarketScan Medicaid Databases.

Davis SA, Lin HC, Balkrishnan R, Feldman SR.

Skin Appendage Disord. 2015 Sep;1(2):65-73. doi: 10.1159/000431037. Epub 2015 Jun 20.

39.

Refined comorbidity index based on dimensionality of comorbidity for use in studies of health-related quality of life.

Ou HT, Lin CY, Erickson SR, Balkrishnan R.

Qual Life Res. 2016 Oct;25(10):2543-2557. doi: 10.1007/s11136-016-1306-6. Epub 2016 Apr 30.

PMID:
27138963
40.

US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Li Y, Robinson B, Abbott KC, Agodoa LY, Ayanian J, Bragg-Gresham J, Balkrishnan R, Chen JL, Cope E, Eggers PW, Gillen D, Gipson D, Hailpern SM, Hall YN, He K, Herman W, Heung M, Hirth RA, Hutton D, Jacobsen SJ, Kalantar-Zadeh K, Kovesdy CP, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, Nguyen DV, O'Hare AM, Plattner B, Pisoni R, Port FK, Rao P, Rhee CM, Sakhuja A, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, White S, Woodside K, Hirth RA.

Am J Kidney Dis. 2016 Mar;67(3 Suppl 1):Svii, S1-305. doi: 10.1053/j.ajkd.2015.12.014. Review. No abstract available.

41.

Spatial Access to Primary Care Providers in Appalachia: Evaluating Current Methodology.

Donohoe J, Marshall V, Tan X, Camacho FT, Anderson RT, Balkrishnan R.

J Prim Care Community Health. 2016 Jul;7(3):149-58. doi: 10.1177/2150131916632554. Epub 2016 Feb 23.

42.

Development and validation of a Hindi language health-related quality of life questionnaire for melasma in Indian patients.

Sarkar R, Garg S, Dominguez A, Balkrishnan R, Jain RK, Pandya AG.

Indian J Dermatol Venereol Leprol. 2016 Jan-Feb;82(1):16-22. doi: 10.4103/0378-6323.168937.

43.

Preparation, validation and user-testing of pictogram-based patient information leaflets for hemodialysis patients.

Mateti UV, Nagappa AN, Attur RP, Bairy M, Nagaraju SP, Mallayasamy S, Vilakkathala R, Guddattu V, Balkrishnan R.

Saudi Pharm J. 2015 Nov;23(6):621-5. doi: 10.1016/j.jsps.2015.01.022. Epub 2015 Feb 4.

44.

Medication Adherence in Children and Adolescents with Acne Vulgaris in Medicaid: A Retrospective Study Analysis.

Hester C, Park C, Chung J, Balkrishnan R, Feldman S, Chang J.

Pediatr Dermatol. 2016 Jan-Feb;33(1):49-55. doi: 10.1111/pde.12713. Epub 2015 Nov 26.

PMID:
26608072
45.

Cross-cultural adaptation, validation and reliability of the South Indian (Kannada) version of the Kidney Disease and Quality of Life (KDQOL-36) instrument.

Mateti UV, Nagappa AN, Attur RP, Nagaraju SP, Mayya SS, Balkrishnan R.

Saudi J Kidney Dis Transpl. 2015 Nov;26(6):1246-52. doi: 10.4103/1319-2442.168662.

46.

Predictors of medication adherence and persistence in Medicaid enrollees with developmental disabilities and type 2 diabetes.

Patel I, Erickson SR, Caldwell CH, Woolford SJ, Bagozzi RP, Chang J, Balkrishnan R.

Res Social Adm Pharm. 2016 Jul-Aug;12(4):592-603. doi: 10.1016/j.sapharm.2015.09.008. Epub 2015 Oct 27.

PMID:
26522400
47.

Predicting Late-stage Breast Cancer Diagnosis and Receipt of Adjuvant Therapy: Applying Current Spatial Access to Care Methods in Appalachia.

Donohoe J, Marshall V, Tan X, Camacho FT, Anderson R, Balkrishnan R.

Med Care. 2015 Nov;53(11):980-8. doi: 10.1097/MLR.0000000000000432.

48.

Adjuvant therapy use among Appalachian breast cancer survivors.

Tan X, Marshall VD, Anderson RT, Donohoe J, Camacho F, Balkrishnan R.

Medicine (Baltimore). 2015 Jul;94(26):e1071. doi: 10.1097/MD.0000000000001071.

49.

US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States.

Saran R, Li Y, Robinson B, Ayanian J, Balkrishnan R, Bragg-Gresham J, Chen JT, Cope E, Gipson D, He K, Herman W, Heung M, Hirth RA, Jacobsen SS, Kalantar-Zadeh K, Kovesdy CP, Leichtman AB, Lu Y, Molnar MZ, Morgenstern H, Nallamothu B, O'Hare AM, Pisoni R, Plattner B, Port FK, Rao P, Rhee CM, Schaubel DE, Selewski DT, Shahinian V, Sim JJ, Song P, Streja E, Kurella Tamura M, Tentori F, Eggers PW, Agodoa LY, Abbott KC.

Am J Kidney Dis. 2015 Jul;66(1 Suppl 1):Svii, S1-305. doi: 10.1053/j.ajkd.2015.05.001. No abstract available. Erratum in: Am J Kidney Dis. 2015 Sep;66(3):545. Am J Kidney Dis. 2015 Sep;66(3):545.

50.

The impact of tailored text messages on health beliefs and medication adherence in adults with diabetes: A randomized pilot study.

Gatwood J, Balkrishnan R, Erickson SR, An LC, Piette JD, Farris KB.

Res Social Adm Pharm. 2016 Jan-Feb;12(1):130-140. doi: 10.1016/j.sapharm.2015.04.007. Epub 2015 Apr 30.

PMID:
25980582

Supplemental Content

Loading ...
Support Center